Roche Holding Non-GAAP EPS of CHF 10.85, revenue of CHF 30.36B
Seeking Alpha ·
Roche Holding press release ( RHHBY ): 1H Non-GAAP EPS of CHF 10.85. Sales in the Pharmaceuticals Division were CHF 23.6 billion (2025: CHF 24.0 billion), an increase of 6% at CER (decrease of 1% in CHF, increase of 8% in USD).
DYAX Investor Sentiment
Bullish (Long) 65% · Bearish (Short) 35%
450 participants
Related News
- 2 Exceptional Growth Stocks That Are Great Buys In 2026
- Thales S.A. Non-GAAP EPS of €4.82, revenue of €10.95B; reaffirms FY2026 outlook
- Additional European Equity News
- Coastal Financial CFO steps down, former CFO appointed to interim post
- Texas Capital anticipates Q3 net interest income of $265M-$270M with NIM of 3.20%-3.25%
- Is Bloom Energy (BE) Undervalued After JPMorgan Backed Its Brookfield AI Power Deal?
